← Back to Clinical Trials
Recruiting NCT05800899

NCT05800899 Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05800899
Status Recruiting
Phase
Sponsor University of Texas, El Paso
Condition Alcohol Use Disorder
Study Type INTERVENTIONAL
Enrollment 600 participants
Start Date 2023-06-30
Primary Completion 2027-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Brief Motivational InterviewingCulturally adaptation brief motivational interviewing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 600 participants in total. It began in 2023-06-30 with a primary completion date of 2027-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This Stage II Randomized Efficacy Trial will compare the effectiveness of a theoretically informed and culturally responsive brief motivational intervention to a non-adapted brief intervention among non-treatment seeking Latinxs admitted for medical treatment of an injury who engage in at risk drinking or were drinking at the time of their injury. The culturally informed brief motivational intervention (CI-BMI) increases autonomous motivation to engage in protective drinking behavior and reduce alcohol problems while addressing barriers to help seeking and facilitating treatment utilization. This project will address the alcohol related health disparities and treatment inequities among Latinx who are more likely to experience alcohol problems yet less likely to receive treatment in order to reduce the negative public health impact of alcohol.

Eligibility Criteria

Inclusion Criteria: * Admission to a level 1 -trauma center * Involved in a alcohol-related injury * Self-identify as Latinx * 18 or older * Minimum Blood Alcohol Concentration (BAC) score of .001 and/or at risk drinking Exclusion Criteria: * Traumatic brain injury or otherwise debilitating injury as indicated by a Glasgow Coma Scale score of less than 15. * Cognitive impairment as indicated by a score of 24 or less on the Mini-Mental Status Exam

Contact & Investigator

Central Contact

Craig A Field, PhD

✉ cfield@utep.edu

📞 (915) 747-8539

Principal Investigator

Deidra Roach, PhD

STUDY CHAIR

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Frequently Asked Questions

Who can join the NCT05800899 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05800899 currently recruiting?

Yes, NCT05800899 is actively recruiting participants. Contact the research team at cfield@utep.edu for enrollment information.

Where is the NCT05800899 trial being conducted?

This trial is being conducted at El Paso, United States.

Who is sponsoring the NCT05800899 clinical trial?

NCT05800899 is sponsored by University of Texas, El Paso. The principal investigator is Deidra Roach, PhD at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology